# MicardisPlus® 複必康平®

USA: Treatment of hypertension alone or with other antihypertensive agents, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Not indicated for initial therapy.

EU: Treatment of essential hypertension. MicardisPlus fixed dose combination is indicated in adults whose blood pressure is not adequately controlled on telmisartan alone.

點擊放大

## Product Key Facts

[中文仿單](/content/tw/disclaimer/external?path=https%3A%2F%2Flmspiq.fda.gov.tw%2Fweb%2FDRPIQ%2FDRPIQ1000Result%3FlicBaseId%3D994A0376-ED19-460B-A3E2-DFBFAE0CB9BA/index.html)

MicardisPlus®

Micardis® Plus

Micardis®HCT

Co-Micardis®

telmisartan, hydrochlorothiazide

##### 透過新聞瞭解更多資訊，請見【 [高血壓](/content/tw/renleichufangyongyao/xinzang/xinxueguanjibing/gaoxueya/index.html)】頁面

### References